Current status of pain management in children

Richard F Howard1

  • 1Anaesthesia and Pain Management, Children Nationwide Pain Research Centre, and Department of Anaesthesia, Great Ormond Street Hospital for Children NHS Trust, London, England. r.howard@ich.ucl.ac.uk

JAMA
|November 13, 2003
PubMed

Insights

Pediatric pain management has advanced, yet effective treatments aren't widely used. Early life pain can cause long-term issues, highlighting the need for more research in children's pain care.

Area of Science:

  • Pediatric Pain Management
  • Developmental Neuroscience
  • Clinical Practice Advancement

Background:

  • Significant progress in understanding pediatric pain and acute pain management has occurred.
  • Despite advances, evidence-based pediatric pain management is not consistently applied in clinical practice.
  • Early life pain experiences are increasingly recognized for their potential long-term consequences.

Purpose of the Study:

  • To review the current state of pediatric pain management.
  • To highlight the gap between research findings and clinical practice.
  • To emphasize the long-term implications of early life pain and the need for further research.

Main Methods:

  • Review of recent findings in laboratory and clinical studies on pediatric pain.
  • Analysis of factors influencing long-term outcomes of infant pain.
  • Assessment of the challenges in managing chronic and neuropathic pain in children.

Main Results:

  • Knowledge regarding safe and effective pain management in children has increased.
  • Research indicates early pain can lead to long-term behavioral changes beyond recovery.
  • Chronic and neuropathic pain are more prevalent in children than previously assumed.

Conclusions:

  • There is a critical need to translate existing knowledge into routine pediatric pain care.
  • Further research is essential to understand and manage the long-term effects of early pain.
  • Improved strategies for assessing and treating chronic pain in children are urgently required.

Related Concept Videos

Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...